Trials / Completed
CompletedNCT04512495
Circulating " Cancer Cells / Macrophage " HYbrid Cells in Patients With Sarcoma?
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Institut Claudius Regaud · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Pilot, prospective, monocentric study aimed at evaluating the rate of patients with circulating "cancer cell/macrophage" hybrid cells in the peripheral blood. The study will be conducted on a population of patients with sarcoma and treated in the context of routine care. For each included patient, blood samples will be collected during baseline visit and after the initiation therapy. At the end of the 2nd blood collection, the patient will have completed his participation in the study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Blood samples will be collected at two times : | * at Baseline, * after surgery or at the time of post-chemotherapy evaluation. |
Timeline
- Start date
- 2020-10-22
- Primary completion
- 2021-12-02
- Completion
- 2021-12-02
- First posted
- 2020-08-13
- Last updated
- 2021-12-10
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04512495. Inclusion in this directory is not an endorsement.